Launching Therapies into a Volatile Market & Strategies to Overcome Compounding Challenges for Successful Introduction & Market Adaptation for New Products

Time: 2:15 pm
day: Conference Day Two


  • Recognizing the increasing challenges arising from multiple cell and gene therapies competing for budgets
  • Assessing the cumulative budget impact of these therapies collectively rather than individually
  • Navigating access and pricing challenges in cell therapy beyond haematology indications to unlock new frontiers and explore opportunities for advancement and patient benefit